212 related articles for article (PubMed ID: 11098088)
1. 5-Aza-2'-deoxycytidine leads to down-regulation of aberrant p16INK4A RNA transcripts and restores the functional retinoblastoma protein pathway in hepatocellular carcinoma cell lines.
Suh SI; Pyun HY; Cho JW; Baek WK; Park JB; Kwon T; Park JW; Suh MH; Carson DA
Cancer Lett; 2000 Nov; 160(1):81-8. PubMed ID: 11098088
[TBL] [Abstract][Full Text] [Related]
2. Re-expression of endogenous p16ink4a in oral squamous cell carcinoma lines by 5-aza-2'-deoxycytidine treatment induces a senescence-like state.
Timmermann S; Hinds PW; Münger K
Oncogene; 1998 Dec; 17(26):3445-53. PubMed ID: 10030668
[TBL] [Abstract][Full Text] [Related]
3. p16INK4a loss and sensitivity in KSHV associated primary effusion lymphoma.
Platt G; Carbone A; Mittnacht S
Oncogene; 2002 Mar; 21(12):1823-31. PubMed ID: 11896614
[TBL] [Abstract][Full Text] [Related]
4. Effect of promoter methylation of the p16 gene on phosphorylation of retinoblastoma gene product and growth of hepatocellular carcinoma cells.
Maeta Y; Shiota G; Okano J; Murawaki Y
Tumour Biol; 2005; 26(6):300-5. PubMed ID: 16254459
[TBL] [Abstract][Full Text] [Related]
5. Demethylation by 5-aza-2'-deoxycytidine (5-azadC) of p16INK4A gene results in downregulation of vascular endothelial growth factor expression in human lung cancer cell lines.
Miki K; Shimizu E; Yano S; Tani K; Sone S
Oncol Res; 2001; 12(8):335-42. PubMed ID: 11589304
[TBL] [Abstract][Full Text] [Related]
6. Multiple mechanisms of p16INK4A inactivation in non-small cell lung cancer cell lines.
Shapiro GI; Park JE; Edwards CD; Mao L; Merlo A; Sidransky D; Ewen ME; Rollins BJ
Cancer Res; 1995 Dec; 55(24):6200-9. PubMed ID: 8521414
[TBL] [Abstract][Full Text] [Related]
7. P53 but not p16INK4a induces growth arrest in retinoblastoma-deficient hepatocellular carcinoma cells.
Morel AP; Unsal K; Cagatay T; Ponchel F; Carr B; Ozturk M
J Hepatol; 2000 Aug; 33(2):254-65. PubMed ID: 10952243
[TBL] [Abstract][Full Text] [Related]
8. Aberrant p16INK4A RNA transcripts expressed in hepatocellular carcinoma cell lines regulate pRb phosphorylation by binding with CDK4, resulting in delayed cell cycle progression.
Cho JW; Jeong YW; Han SW; Park JB; Jang BC; Baek WK; Kwon TK; Park JW; Kim SP; Suh MH; Suh SI
Liver Int; 2003 Jun; 23(3):194-200. PubMed ID: 12955883
[TBL] [Abstract][Full Text] [Related]
9. Hypermethylation of growth arrest DNA damage-inducible gene 45 beta promoter in human hepatocellular carcinoma.
Qiu W; Zhou B; Zou H; Liu X; Chu PG; Lopez R; Shih J; Chung C; Yen Y
Am J Pathol; 2004 Nov; 165(5):1689-99. PubMed ID: 15509538
[TBL] [Abstract][Full Text] [Related]
10. Aberrant CpG island hypermethylation and down-regulation of Oct-6 mRNA expression in human hepatocellular carcinoma.
Sun JZ; Yang XX; Li XH; Xu WW; Wang Y; Zhu W; Li M
Dig Dis Sci; 2011 Oct; 56(10):3072-7. PubMed ID: 21448695
[TBL] [Abstract][Full Text] [Related]
11. Hypermethylation of the p16 (Ink4a) promoter in B6C3F1 mouse primary lung adenocarcinomas and mouse lung cell lines.
Patel AC; Anna CH; Foley JF; Stockton PS; Tyson FL; Barrett JC; Devereux TR
Carcinogenesis; 2000 Sep; 21(9):1691-700. PubMed ID: 10964101
[TBL] [Abstract][Full Text] [Related]
12. Methylation status of genes upregulated by demethylating agent 5-aza-2'-deoxycytidine in hepatocellular carcinoma.
Hirasawa Y; Arai M; Imazeki F; Tada M; Mikata R; Fukai K; Miyazaki M; Ochiai T; Saisho H; Yokosuka O
Oncology; 2006; 71(1-2):77-85. PubMed ID: 17341888
[TBL] [Abstract][Full Text] [Related]
13. Hypermethylation and transcriptional downregulation of the carboxyl-terminal modulator protein gene in glioblastomas.
Knobbe CB; Reifenberger J; Blaschke B; Reifenberger G
J Natl Cancer Inst; 2004 Mar; 96(6):483-6. PubMed ID: 15026474
[TBL] [Abstract][Full Text] [Related]
14. [Disfigurement of p16INK4A gene expression in development of ovarian cancer and the mechanism].
Li M; Huang ZJ; Dong WH; Li XY; Wang XY; He XH; Wang H; Wang ZH
Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):408-12. PubMed ID: 16831366
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulation of the Wnt signaling inhibitor DACT2 in human hepatocellular carcinoma.
Zhang X; Yang Y; Liu X; Herman JG; Brock MV; Licchesi JD; Yue W; Pei X; Guo M
Epigenetics; 2013 Apr; 8(4):373-82. PubMed ID: 23449122
[TBL] [Abstract][Full Text] [Related]
16. Aberrant methylation and downregulation of sall3 in human hepatocellular carcinoma.
Yang XX; Sun JZ; Li FX; Wu YS; Du HY; Zhu W; Li XH; Li M
World J Gastroenterol; 2012 Jun; 18(21):2719-26. PubMed ID: 22690083
[TBL] [Abstract][Full Text] [Related]
17. Effects of exogenous p16INK4a on growth of cells with various status of cell-cycle regulators.
Suzuki-Takahashi I; Higashi H; Yoshida E; Nishimura S; Kitagawa M
Biochem Biophys Res Commun; 1997 May; 234(2):386-92. PubMed ID: 9177281
[TBL] [Abstract][Full Text] [Related]
18. [The study of 5-Aza-2'-deoxycytidine on transcription regulation of p16/CDKN2 gene demethylation in RKO human colorectal cell line].
Fang XM; Sun LF; Peng JP; Dong Q; Zheng S
Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(23):2077-82. PubMed ID: 14703421
[TBL] [Abstract][Full Text] [Related]
19. Decitabine induces cell cycle arrest at the G1 phase via p21(WAF1) and the G2/M phase via the p38 MAP kinase pathway.
Lavelle D; DeSimone J; Hankewych M; Kousnetzova T; Chen YH
Leuk Res; 2003 Nov; 27(11):999-1007. PubMed ID: 12859993
[TBL] [Abstract][Full Text] [Related]
20. Promoter hypermethylation of DLC-1, a candidate tumor suppressor gene, in several common human cancers.
Yuan BZ; Durkin ME; Popescu NC
Cancer Genet Cytogenet; 2003 Jan; 140(2):113-7. PubMed ID: 12645648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
